Back to Screener

Precision Optics Corporation, Inc. Common Stock (POCI)

Price$4.70

Favorite Metrics

Price vs S&P 500 (26W)-1.00%
Price vs S&P 500 (4W)1.35%
Market Capitalization$48.96M

All Metrics

Book Value / Share (Quarterly)$1.21
P/TBV (Annual)3.12x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)6.78%
Cash Flow / Share (Quarterly)$-0.41
Price vs S&P 500 (YTD)4.41%
Gross Margin (TTM)9.70%
Net Profit Margin (TTM)-28.33%
EPS (TTM)$-0.93
10-Day Avg Trading Volume0.04M
EPS Excl Extra (TTM)$-0.93
Revenue Growth (5Y)13.99%
EPS (Annual)$-0.85
ROI (Annual)-40.84%
Gross Margin (Annual)17.83%
Net Profit Margin (5Y Avg)-10.65%
Cash / Share (Quarterly)$0.11
Revenue Growth QoQ (YoY)62.76%
ROA (Last FY)-29.21%
Revenue Growth TTM (YoY)30.69%
EBITD / Share (TTM)$-0.86
ROE (5Y Avg)-18.18%
Operating Margin (TTM)-27.57%
Cash Flow / Share (Annual)$-0.49
P/B Ratio5.25x
P/B Ratio (Quarterly)3.46x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.03x
Net Interest Coverage (TTM)-24.45x
ROA (TTM)-32.67%
EV / EBITDA (TTM)171.26x
EPS Incl Extra (Annual)$-0.85
Current Ratio (Annual)1.64x
Quick Ratio (Quarterly)0.58x
3-Month Avg Trading Volume0.02M
52-Week Price Return6.52%
EV / Free Cash Flow (Annual)2683.65x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.18
P/S Ratio (Annual)2.56x
Asset Turnover (Annual)0.96x
52-Week High$6.04
Operating Margin (5Y Avg)-9.76%
EPS Excl Extra (Annual)$-0.85
CapEx CAGR (5Y)7.85%
Tangible BV CAGR (5Y)41.75%
26-Week Price Return2.99%
Quick Ratio (Annual)0.99x
13-Week Price Return7.18%
Total Debt / Equity (Annual)0.15x
Current Ratio (Quarterly)1.05x
Enterprise Value$49.665
Revenue / Share Growth (5Y)4.18%
Asset Turnover (TTM)1.15x
Book Value / Share Growth (5Y)64.28%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)4.88x
Pretax Margin (Annual)-30.27%
Cash / Share (Annual)$0.23
3-Month Return Std Dev62.59%
Gross Margin (5Y Avg)29.70%
Net Income / Employee (TTM)$-0
ROE (Last FY)-47.15%
Net Interest Coverage (Annual)-36.73x
EPS Basic Excl Extra (Annual)$-0.85
P/FCF (TTM)73.07x
Receivables Turnover (TTM)5.83x
Total Debt / Equity (Quarterly)0.17x
EPS Incl Extra (TTM)$-0.93
Receivables Turnover (Annual)4.84x
ROI (TTM)-52.24%
P/S Ratio (TTM)2.01x
Pretax Margin (5Y Avg)-10.65%
Revenue / Share (Annual)$2.81
Tangible BV / Share (Annual)$1.56
Price vs S&P 500 (52W)-5.91%
Year-to-Date Return7.05%
5-Day Price Return12.28%
EPS Normalized (Annual)$-0.85
ROA (5Y Avg)-10.91%
Net Profit Margin (Annual)-30.28%
Month-to-Date Return2.05%
Cash Flow / Share (TTM)$-0.04
EBITD / Share (Annual)$-0.79
Operating Margin (Annual)-29.08%
LT Debt / Equity (Annual)0.11x
ROI (5Y Avg)-14.97%
LT Debt / Equity (Quarterly)0.11x
EPS Basic Excl Extra (TTM)$-0.93
P/TBV (Quarterly)3.54x
P/B Ratio (Annual)3.06x
Inventory Turnover (TTM)5.44x
Pretax Margin (TTM)-28.32%
Book Value / Share (Annual)$1.59
Price vs S&P 500 (13W)6.49%
Beta1.06x
P/FCF (Annual)611.98x
Revenue / Share (TTM)$3.16
ROE (TTM)-60.56%
52-Week Low$3.55

Industry Peers — Electromedical Equipment(29)

SymbolP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
POCIPrecision Optics Corporation, Inc. Common Stock
2.01x13.99%9.70%-27.57%$4.70
MDTMedtronic plc
3.13x3.01%65.16%17.00%$85.65
MASIMasimo Corporation
6.12x5.95%61.90%20.30%$178.29
TMDXTransMedics Group, Inc. Common Stock
6.58x88.21%59.92%17.93%$109.12
LIVNLivaNova PLC Ordinary Shares
2.56x8.24%68.04%14.09%$65.01
ITGRInteger Holdings Corporation
1.63x11.55%27.39%11.90%$88.37
AXGNAxogen, Inc. Common Stock
7.92x14.93%74.31%-3.49%$37.37
CNMDCONMED Corporation
0.88x9.77%54.59%7.46%$37.91
BLFSBioLife Solutions Inc.
10.59x14.87%64.56%-17.26%$20.85
INMDInMode Ltd. Ordinary Shares
2.45x12.45%78.54%23.05%$14.33
CBLLCeriBell, Inc. Common Stock
8.68x87.89%-65.57%$20.74

About

Precision Optics Corp manufactures advanced optical instruments for medical, industrial, and military markets. The company specializes in endoscopes and custom optical devices for minimally invasive surgical and diagnostic procedures, while also producing optical components and assemblies for industrial and military applications. Substantially all revenue is generated in the United States.